Widdrol, a natural
sesquiterpene present in Juniperus sp., has been shown to exert anticancer and antifungal effects. Emerging evidence has suggested that
AMP-activated protein kinase (AMPK), which functions as a cellular energy sensor, is a potential therapeutic target for human
cancers. In this study, we found that AMPK mediates the anticancer effects of
widdrol through induction of apoptosis in HT-29
colon cancer cells. We showed that
widdrol induced the phosphorylation of AMPK in a dose- and time-dependent manner. The selective
AMPK inhibitor compound C abrogated the inhibitory effect of
widdrol on HT-29 cell growth. In addition, we demonstrated that
widdrol induced apoptosis and this was associated with the activation of
caspases, including caspase‑3/7 and
caspase-9, in HT-29 cells. We also demonstrated that transfection of HT-29 cells with AMPK siRNAs significantly suppressed the
widdrol-mediated apoptosis and the activation of
caspases. However, cell cycle arrest induced by
widdrol was not affected by transfection of HT-29 cells with AMPK siRNAs. Furthermore,
widdrol inhibited HT-29
tumor growth in a human
tumor xenograft model. Taken together, our results suggest that the anticancer effect of
widdrol may be mediated, at least in part, by induction of apoptosis via AMPK activation.